Related Experiment Video

Updated: Apr 9, 2026

Microbiota Analysis Using Two-step PCR and Next-generation 16S rRNA Gene Sequencing
11:22

Microbiota Analysis Using Two-step PCR and Next-generation 16S rRNA Gene Sequencing

Published on: October 15, 2019

31.6K

The gut microbiota and liver disease

Cristina Llorente1, Bernd Schnabl1

  • 1Department of Medicine, University of California San Diego, La Jolla, CA, and Department of Medicine, VA San Diego Healthcare System, San Diego, CA.

Cellular and Molecular Gastroenterology and Hepatology
|June 20, 2015
PubMed

Insights

Gut microbiota changes, known as dysbiosis, are increasingly linked to liver disease development. Understanding these microbial shifts is key to developing new liver disease therapies.

Area of Science:

  • Gastroenterology and Hepatology
  • Microbiology
  • Immunology

Background:

  • The gut microbiota plays a crucial role in digestion, immune modulation, and producing metabolites.
  • Dysbiosis, an imbalance in gut microbial communities, is implicated in various health conditions.
  • The leaky gut hypothesis historically linked microbial products to liver disease progression.

Purpose of the Study:

  • To review the factors causing gut dysbiosis.
  • To discuss how dysbiosis disrupts intestinal homeostasis.
  • To explore the contribution of dysbiosis to liver disease pathophysiology.

Main Methods:

  • Literature review focusing on gut microbiota and liver disease.
  • Analysis of host-bacteria interactions and microbial metabolic products.
  • Examination of qualitative and quantitative changes in gut microbiota.

Main Results:

  • Dysbiosis, characterized by altered bacterial proportions (harmful vs. beneficial) and overgrowth, is associated with liver disease.
  • Disrupted intestinal homeostasis due to dysbiosis contributes to liver disease.
  • Microbial products and host-bacteria interactions influence disease susceptibility.

Conclusions:

  • Understanding the gut microbiota's role in liver disease is essential for therapeutic advancements.
  • Targeting dysbiosis may offer innovative strategies for treating liver diseases.
  • Further research into the mechanisms linking gut dysbiosis and liver pathophysiology is warranted.

More Related Videos

Therapeutic Evaluation of Fecal Microbiota Transplantation in an Interleukin 10-Deficient Mouse Model05:41

Therapeutic Evaluation of Fecal Microbiota Transplantation in an Interleukin 10-Deficient Mouse Model

Published on: April 6, 2022

3.6K
Applying Advanced In Vitro Culturing Technology to Study the Human Gut Microbiota06:23

Applying Advanced In Vitro Culturing Technology to Study the Human Gut Microbiota

Published on: February 15, 2019

15.0K

Related Concept Videos

Functions of the Gut Microbiota01:18

Functions of the Gut Microbiota

The gut microbiota includes trillions of microorganisms that colonize the human gastrointestinal tract, including bacteria, archaea, viruses, and fungi. This complex ecosystem plays a critical role in maintaining intestinal and systemic health. Most of these microbes inhabit the large intestine, establishing a relatively stable and diverse community that contributes to gut homeostasis through various metabolic, immunological, and protective mechanisms.Dominant bacterial phyla, such as...
78
Microbiota of the Large Intestine01:27

Microbiota of the Large Intestine

The large intestine hosts the most densely populated microbial ecosystem in the human body. This complex community primarily consists of anaerobic bacteria, with Bacillota (formerly Firmicutes) and Bacteroidota (formerly Bacteroidetes) as the predominant groups. The distribution of these microbes varies along different sections of the large intestine, influenced by local environmental factors such as oxygen availability and nutrient composition.The cecum, located at the beginning of the large...
59
Microbiota of the Stomach and Small Intestine01:27

Microbiota of the Stomach and Small Intestine

The human gastrointestinal (GI) tract is characterized by distinct physicochemical conditions that shape its microbial communities. Among these, the stomach presents a particularly challenging environment for microbial colonization due to its highly acidic pH, ranging from 1 to 3. This extreme acidity effectively limits microbial density. However, certain acid-tolerant microorganisms are capable of surviving in this niche. Notably, Helicobacter pylori can colonize the gastric mucosa,...
54
Diseases of the Liver and Gallbladder01:26

Diseases of the Liver and Gallbladder

Liver and gallbladder diseases are a significant health concern, with prominent conditions including cirrhosis, hepatitis, non-alcoholic fatty liver disease (NAFLD), and gallstones. Jaundice is a common manifestation of liver and biliary disease.
Cirrhosis is characterized by the scarring of hepatic lobules in the liver, which are replaced by fibrous tissue, affecting the liver's normal functioning. NAFLD, on the other hand, is caused by an excessive build-up of fat in the liver, not...
2.4K
Gut-Brain Axis01:22

Gut-Brain Axis

The gut–brain axis is a bidirectional communication system that connects the gastrointestinal tract and the brain. This interaction is mediated through multiple pathways, including the vagus nerve, hormonal signals, immune responses, and chemical messengers produced by gut microbes.Microbial Contributions to Brain FunctionGut microbiota contributes significantly to brain function by producing neuroactive compounds. These include neuroactive compounds that influence neurotransmitters such...
84
Introduction to the Human Microbiota01:22

Introduction to the Human Microbiota

Microorganisms colonize various regions of the human body, including the mouth, nasal passages, throat, stomach, intestines, urogenital tract, and skin. The total number of microbial cells is estimated to range from 10¹³ to 10¹⁴—comparable to, or exceeding, the number of human somatic cells. This host–microbiome relationship has led to the conceptualization of humans as supraorganisms, wherein microbial communities perform vital roles in development, immunity,...
91